Main Menu
KOMBIGLYZE - XR - New Type 2 Diabetes Medication Released
The FDA approved the new type 2 diabetes medication Kombiglyze - XR on November 5, 2010. It is now available by prescription in the United States. The medication comes in the form of a tablet and is taken once a day. It works well with a controlled diet and exercise program.
Kombiglyze - XR
Kombiglyze - XR is the first once a day metformin extended-release (XR) plus dipeptidyl peptidase-4 (DPP-4) inhibitor combination. in one tablet for the treatment of type 2 diabetes. KOMBIGLYZE XR should generally be administered once a day with the evening meal, with gradual dose titration to reduce the gastrointestinal side effects associated with metformin. The maximum daily recommended dose is 5 mg for saxagliptin and 2,000 mg for metformin extended-release.
Conclusion
Kombiglyze - XR is to be used for patients with type 2 diabetes. It is not to be used with type 1 diabetics. Doctors are hopeful that the new once a day medication will help patients gain better management over their diabetes. It is a lot easier to take one pill a day then four pills a day.
Source: http://www.medicalnewstoday.com/articles/213242.php
The information provided on InformationAboutDiabetes.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational purposes and does not constitute the practice of medicine. We encourage all visitors to see a licensed physician or nutritionist if they have any concerns regarding health issues related to diet, personal image and any other topics discussed on this site. Neither the owners or employees of InformationAboutDiabetes.com nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.


